Company Profiles

driven by the PitchBook Platform

Anchor Therapeutics

Description

Developer of pharmaceutical candidates to address cancer, inflammation, metabolism, heart disease and pain. The company develops Pepducin lipopeptide drug candidates, which are molecules that target the intracellular domains of G protein coupled receptors (GPCRs) to allosterically modulate GPCR signaling.

2006

Founded

PRIVATE

Status

11-50

Employees

Early Stage VC

Latest Deal Type

$34M

Total Amount Raised

3

Investors

Description

Developer of pharmaceutical candidates to address cancer, inflammation, metabolism, heart disease and pain. The company develops Pepducin lipopeptide drug candidates, which are molecules that target the intracellular domains of G protein coupled receptors (GPCRs) to allosterically modulate GPCR signaling.

Website:

www.anchortx.com

Formerly Known As

Ascent Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

One Kendall Square Building 200, Suite 2203 Cambridge, MA 02139United States +1 (617) 715-1999
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Anchor Therapeutics's full profile, request a free trial.

Anchor Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Anchor Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Anchor Therapeutics Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
HealthCare VenturesVenture CapitalMinority000 0000000 0000
Novartis Venture FundsCorporate Venture CapitalMinority000 0000000 0000
TVM CapitalVenture CapitalMinority000 0000000 0000
HealthCare Ventures Venture Capital
Novartis Venture Funds Corporate Venture Capital
TVM Capital Venture Capital

Anchor Therapeutics Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Thomas McMurry Ph.DSenior Vice President, Preclinical Research & Development & Acting President
Thomas McMurry Ph.D Senior Vice President, Preclinical Research & Development & Acting President

Anchor Therapeutics Board Members (6)

NameRepresentingRoleSinceContact
Info
Christopher Mirabelli Ph.DHealthCare VenturesManaging Director000 0000
Cynthia Lavoie Ph.DTVM CapitalBoard Member000 0000
Jochen Knolle Ph.DSelfBoard Member000 0000
Lauren Silverman Ph.DNovartis Venture FundsManaging Director000 0000
Michael Berendt Ph.DSelfBoard Member & Executive Chairman000 0000
Christopher Mirabelli Ph.D Managing Director HealthCare Ventures
Cynthia Lavoie Ph.D Board Member TVM Capital
Jochen Knolle Ph.D Board Member Self
Lauren Silverman Ph.D Managing Director Novartis Venture Funds
Michael Berendt Ph.D Board Member & Executive Chairman Self
Request full access to PitchBook